Geode Capital Management
CPRX icon

Geode Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$62.2M Buy
2,866,683
+101,127
+4% +$2.19M ﹤0.01% 1313
2025
Q1
$67.1M Buy
2,765,556
+100,084
+4% +$2.43M 0.01% 1202
2024
Q4
$55.6M Buy
2,665,472
+1,048
+0% +$21.9K ﹤0.01% 1363
2024
Q3
$53M Sell
2,664,424
-34,189
-1% -$680K ﹤0.01% 1391
2024
Q2
$41.8M Buy
2,698,613
+190,461
+8% +$2.95M ﹤0.01% 1471
2024
Q1
$40M Buy
2,508,152
+307,927
+14% +$4.91M ﹤0.01% 1509
2023
Q4
$37M Buy
2,200,225
+113,858
+5% +$1.91M ﹤0.01% 1524
2023
Q3
$24.4M Buy
2,086,367
+159,952
+8% +$1.87M ﹤0.01% 1699
2023
Q2
$25.9M Buy
1,926,415
+72,193
+4% +$970K ﹤0.01% 1682
2023
Q1
$30.7M Buy
1,854,222
+90,832
+5% +$1.51M ﹤0.01% 1517
2022
Q4
$32.8M Buy
1,763,390
+76,269
+5% +$1.42M ﹤0.01% 1441
2022
Q3
$21.6M Sell
1,687,121
-4,671
-0.3% -$59.9K ﹤0.01% 1669
2022
Q2
$11.9M Sell
1,691,792
-62,178
-4% -$436K ﹤0.01% 2135
2022
Q1
$14.5M Buy
1,753,970
+23,657
+1% +$196K ﹤0.01% 2099
2021
Q4
$11.7M Sell
1,730,313
-166,663
-9% -$1.13M ﹤0.01% 2343
2021
Q3
$10.1M Buy
1,896,976
+32,343
+2% +$171K ﹤0.01% 2453
2021
Q2
$10.7M Buy
1,864,633
+97,768
+6% +$562K ﹤0.01% 2410
2021
Q1
$8.15M Buy
1,766,865
+164,171
+10% +$757K ﹤0.01% 2499
2020
Q4
$5.35M Buy
1,602,694
+54,666
+4% +$183K ﹤0.01% 2568
2020
Q3
$4.6M Sell
1,548,028
-26,464
-2% -$78.6K ﹤0.01% 2437
2020
Q2
$7.27M Buy
1,574,492
+33,135
+2% +$153K ﹤0.01% 2115
2020
Q1
$5.93M Buy
1,541,357
+37,036
+2% +$143K ﹤0.01% 2041
2019
Q4
$5.64M Sell
1,504,321
-19,083
-1% -$71.5K ﹤0.01% 2380
2019
Q3
$8.09M Buy
1,523,404
+119,613
+9% +$635K ﹤0.01% 2073
2019
Q2
$5.39M Buy
1,403,791
+257,369
+22% +$988K ﹤0.01% 2332
2019
Q1
$5.85M Buy
1,146,422
+82,654
+8% +$421K ﹤0.01% 2238
2018
Q4
$2.04M Buy
1,063,768
+101,584
+11% +$195K ﹤0.01% 2761
2018
Q3
$3.64M Buy
962,184
+1,616
+0.2% +$6.11K ﹤0.01% 2569
2018
Q2
$3M Buy
960,568
+104,720
+12% +$327K ﹤0.01% 2614
2018
Q1
$2.05M Buy
855,848
+109,837
+15% +$262K ﹤0.01% 2745
2017
Q4
$2.92M Buy
746,011
+118,799
+19% +$464K ﹤0.01% 2537
2017
Q3
$1.58M Buy
627,212
+13,363
+2% +$33.7K ﹤0.01% 2874
2017
Q2
$1.69M Buy
613,849
+151,172
+33% +$417K ﹤0.01% 2825
2017
Q1
$902K Buy
462,677
+1,446
+0.3% +$2.82K ﹤0.01% 3066
2016
Q4
$484K Buy
461,231
+964
+0.2% +$1.01K ﹤0.01% 3276
2016
Q3
$501K Buy
460,267
+241
+0.1% +$262 ﹤0.01% 3246
2016
Q2
$326K Sell
460,026
-19,961
-4% -$14.1K ﹤0.01% 3396
2016
Q1
$561 Buy
479,987
+4,314
+0.9% +$5 ﹤0.01% 3163
2015
Q4
$1.17M Buy
475,673
+5,601
+1% +$13.7K ﹤0.01% 2821
2015
Q3
$1.41M Buy
470,072
+62,085
+15% +$186K ﹤0.01% 2666
2015
Q2
$1.68M Buy
407,987
+55,139
+16% +$228K ﹤0.01% 2607
2015
Q1
$1.53M Buy
352,848
+87,104
+33% +$377K ﹤0.01% 2607
2014
Q4
$789K Sell
265,744
-16,590
-6% -$49.3K ﹤0.01% 2973
2014
Q3
$937K Sell
282,334
-14,926
-5% -$49.5K ﹤0.01% 2812
2014
Q2
$751K Buy
297,260
+123,472
+71% +$312K ﹤0.01% 2971
2014
Q1
$392K Buy
173,788
+8,370
+5% +$18.9K ﹤0.01% 3250
2013
Q4
$322K Hold
165,418
﹤0.01% 3258
2013
Q3
$505K Hold
165,418
﹤0.01% 2942
2013
Q2
$147K Buy
+165,418
New +$147K ﹤0.01% 3331